Overview

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Status:
Completed
Trial end date:
2021-10-26
Target enrollment:
Participant gender:
Summary
Study to assess the efficacy and safety of XC8, film-coated tablets, 10 mg in comparison with placebo in patients with dry non-productive cough against acute respiratory infections, and to determine the dosing regimen of XC8, film-coated tablets, 10 mg for treatment of dry non-productive cough against acute respiratory infections.
Phase:
Phase 2
Details
Lead Sponsor:
Valenta Pharm JSC